Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 18627948422 |
| E-mail: | sale@hdimpurity.com |
| QQ: | 3001016691 |
| Skype: | Chat Now! |
| Address: | Biwangxin Technology Building 503, Biwangxin High-tech Industrial Park, Xili Street, Nanshan District, Shenzhen |
|
ShenZhen H&D Pharmaceutical Technology Co., LTD is a professional supplier of pharmaceutical impurity control products. Short product delivery time, covering more than 90% of cutting-edge generic drug projects; All products must be checked for LCMS and HPLC within one year. We offer custom synthesis and preparation of small molecule compounds.
The company has its own research and development center, focusing on providing pharmaceutical research and development units with new drug and generic drug registration and application of chemical products, including drug standards, drug impurity reference products, characteristic intermediates, analytical testing and custom compound synthesis services. Our delivery standard is not less than 98% purity (HPLC).
The company focuses on providing pharmaceutical research and development units with new drug and generic drug registration applications and chemical products, including drug impurity reference products, standards, pharmaceutical intermediates, as well as drug impurity preparation, separation and purification business.
|
|
| Product Name | MF | CAS | Details |
|---|
| Dapoxetine impurity 54 | Details |
| Dapoxetine impurity 56 | Details |
| Dapoxetine impurity 52 | C9H9Cl | 21087-29-6 | Details |
| Dapoxetine Impurity 50 | C11H17N | 3330-05-0 | Details |
| Dapoxetine impurity 51 | Details |
| Dapoxetine Impurity 48 | C19H19NO | 119357-34-5 | Details |
| Dapoxetine impurity 32 | Details |
| Dapoxetine impurity 42 | C11H10O3S | 38262-42-9 | Details |
| Dapoxetine impurity 38 | C9H11NO2 | 40856-44-8 | Details |
| Dapoxetine impurity 40 | C10H8O | 135-19-3 | Details |
| Dapoxetine impurity 41 | Details |
| Dapoxetine impurity 46 | C9H11NO2 | 13921-90-9 | Details |
| Dapoxetine impurity 47 | C20H21NO | 119357-18-5 | Details |
| Dapoxetine impurity 25 | C15H16O | 14097-24-6 | Details |
| Dapoxetine impurity 24 | C20H20O4S | 1445281-20-8 | Details |
| Dapoxetine impurity 26 | Details |
| Dapoxetine impurity 28 | C9H10O2 | 501-52-0 | Details |
| Dapoxetine impurity 17 | Details |
| Dapoxetine impurity 6 | Details |
| Dapoxetine impurity 8 | C19H16O | 1091626-77-5 | Details |
| Dapoxetine impurity 16 | Details |
| Dapoxetine impurity 16 (Hydrochloride) | Details |
| Fenofibrate EP Impurity E | C19H19ClO4 | 42019-08-9 | Details |
| Fenofibrate | C20H21ClO4 | 49562-28-9 | Details |
| Fenofibrate Impurity 2 | C13H9ClO2 | 42019-78-3 | Details |
| Fenofibrate EP Impurity B | C17H15ClO4 | 42017-89-0 | Details |
| Fenofibrate EP Impurity C | C17H15ClO3 | 217636-47-0 | Details |
| Lidocaine Impurity 28 | C20H22N2O2 | 70336-49-1 | Details |
| Lidocaine Impurity 29 | C18H22N2O | 294852-91-8 | Details |
| Dapoxetine Impurity 12 | C30H32ClNO2 | 2242008-38-2 | Details |
| Dapoxetine impurity 14 | C21H23NO2 | 1346603-24-4 | Details |
| Dapoxetine impurity 3 (hydrochloride) | C21H24ClNO | 156453-51-9 | Details |
| Dapoxetine impurity 4 | Details |
| Dapoxetine impurity 3 | C21H23NO | 119357-36-7 | Details |
| Dapoxetine impurity 13 | C19H16O | 94305-25-6 | Details |
| Dapoxetine impurity 67 | Details |
| Dapoxetine impurity 70 | C10H8O | 90-15-3 | Details |
| Dapoxetine Impurity 72 | C17H19NO | 112068-01-6 | Details |
| Dapoxetine Impurity 76 | C10H10O | 529-34-0 | Details |
| Dapoxetine Impurity 80 | C9H12O2 | 103548-16-9 | Details |
| Dapoxetine Impurity 81 | C28H28O3 | 2415108-74-4 | Details |
| Lidocaine EP Impurity F | C14H22N2O | 142713-08-4 | Details |
| Lidocaine Impurity 14 | C10H12ClNO | 2564-07-0 | Details |
| Lidocaine EP Impurity G(Hydrochloride) | C13H21ClN2O | 35891-87-3 | Details |
| Lidocaine Impurity 18 | C10H12ClNO | 39106-10-0 | Details |
| Lidocaine Impurity 2 | C14H23ClN2O | 73-78-9 | Details |
| Lidocaine Impurity 3 | C11H16N2O.ClH | 35891-84-0 | Details |
| Lidocaine Impurity 4 | C11H16N2O | 42459-27-8 | Details |
| Lidocaine EP Impurity C | C10H13NO | 2198-53-0 | Details |
| Lidocaine EP Impurity D(Hydrochloride) | C12H19ClN2O | 7729-94-4 | Details |
| Lidocaine EP Impurity E | C20H25N3O2 | 745798-07-6 | Details |
| Lidocaine Impurity 11 | C20H26ClN3O2 | 1135231-62-7 | Details |
| Tofacitinib Impurity 92 | Details |
| Tofacitinib Impurity 87 | Details |
| Tofacitinib Impurity 91 | Details |
| Tofacitinib Impurity 81 | Details |
| Tofacitinib Impurity 85 | C20H24ClN5 | 2268720-86-9 | Details |
| Tofacitinib Impurity 86 | Details |
| Lidocaine EP Impurity J | C14H22N2O | 857570-37-7 | Details |
| Lidocaine Impurity 23 | C10H12ClNO | 5177-35-5 | Details |
| Lidocaine EP Impurity K(Hydrochloride) | C13H21ClN2O | 50295-20-0 | Details |
| Lidocaine Impurity 26 | C12H18N2O.ClH | 31785-64-5 | Details |
| Lidocaine Impurity 27 | C12H18N2O | 21236-54-4 | Details |
| Dapagliflozin Impurity 21 | C21H25ClO6 | 2040305-05-1 | Details |
| Dapagliflozin Impurity 33 | Details |
| Dapagliflozin Impurity 3 | C19H21ClO6 | 864070-37-1 | Details |
| Dapagliflozin Impurity 55 | C7H3BrCl2O | 21900-52-7 | Details |
| Dapagliflozin Propanediol Hydrate | C24H33ClO8 | 960404-48-2 | Details |
| Dapagliflozin Impurity E | C30H28Cl2O2 | 2176485-21-3 | Details |
| Dapagliflozin | C21H25ClO6 | 461432-26-8 | Details |
| Dapagliflozin Impurity 6 | C21H25BrO6 | 1807632-95-6 | Details |
| Dapagliflozin Impurity 8 | C15H12ClIO2 | 2305949-33-9 | Details |
| Dapagliflozin Impurity 9 | C15H14ClIO | 2305949-36-2 | Details |
| Dapoxetine Impurity 85 | C10H11NO | 24241-74-5 | Details |
| Dapoxetine impurity 88 | C19H18O | 119357-48-1 | Details |
| Dapoxetine Impurity 87 | C10H6O2 | 613-20-7 | Details |
| Dapoxetine Impurity 86 | C12H13N | 2436-85-3 | Details |
| Dapoxetine Impurity 82(Hydrochloride) | Details |
| Dapoxetine Impurity 79 | C9H12O | 1565-74-8 | Details |
| Dapoxetine Impurity 84 | C19H16O | 149045-41-0 | Details |
| Dapoxetine Impurity 83 | Details |
| Dapoxetine Impurity 77 | C9H11ClO | 100306-34-1 | Details |
| Dapoxetine Impurity 75 | C30H31NO | 2245197-07-1 | Details |
| Dapoxetine impurity 37 | C9H9ClO | 936-59-4 | Details |
| Fenofibrate Impurity 17 | Details |
| Fenofibrate EP Impurity G | C24H27ClO6 | 217636-48-1 | Details |
| Fenofibrate Impurity 1 | C17H16O5 | 61002-27-5 | Details |
| Dapoxetine impurity 29 | C15H14O | 1083-30-3 | Details |
| Dapoxetine Impurity 5 | C20H22ClNO | 157166-71-7 | Details |
| Dapoxetine impurity 2 | C19H18O2 | 156453-50-8 | Details |
| Dapoxetine impurity 44 | C19H16O2 | 41198-42-9 | Details |
| Dapoxetine impurity 14 (Hydrochloride) | Details |
| Dapoxetine impurity 15 | C19H18O2 | 908291-72-5 | Details |
| Dapoxetine impurity 21 | C9H9Cl | 2687-12-9 | Details |
| Dapoxetine impurity 30 | C10H6O2 | 130-15-4 | Details |
| Dapoxetine impurity 31 | C10H6O2 | 524-42-5 | Details |
| Dapoxetine impurity 33 | Details |
| Dapoxetine impurity 43 | C28H26O3 | 2242008-36-0 | Details |
| Dapoxetine impurity 45 | C28H26O2 | 2245197-11-7 | Details |
| Dapoxetine impurity 47(Hydrochlorate) | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 | ||||